Literature DB >> 33039912

Explore of the beneficial effects of Huang-Lian-Jie-Du Decoction on diabetic encephalopathy in db/db mice by UPLC-Q-Orbitrap HRMS/MS based untargeted metabolomics analysis.

Wen-Jiao He1, Dong-Min Cao1, Yun-Bo Chen2, Jing-Jing Shi2, Tian Hu2, Zhi-Tong Zhang1, Tian Lan3, Dan Tang4, Shu-Mei Wang5.   

Abstract

Diabetic encephalopathy (DE) is a severe diabetic complication with cognitive dysfunction. Huang-Lian-Jie-Du Decoction (HLJDD), a famous traditional Chinese formula, is effective for the treatment of diabetes mellitus and Alzheimer's disease in clinical practices, however, the therapeutic effects and the underlying mechanisms of HLJDD on DE is unclear yet. With this purpose, behavior test, brain histological and biochemical analysis were estimated to assess the beneficial effects of HLJDD on DE. Plasma samples were collected for metabolomics analysis based on UPLC-Q-Orbitrap HRMS/MS and chemometric analysis. As a result, morris water maze test revealed that HLJDD could effectively improve the learning and memory abilities in db/db mice. Brain histological and biochemical analysis indicated that HLJDD could protect against neurodegeneration and oxidative stress in db/db mice. Meanwhile, a total of 21 potential biomarkers with significant differences were identified between Model group and Control group using untargeted metabolomics strategy. Among them, 11 metabolites showed a trend towards the normal levels after HLJDD intervention. These metabolites principally involved in glycerophospholipid metabolism, fatty acid β-oxidation, linoleic acid metabolism, glucose metabolism and glutathione metabolism based on the metabolic pathway analysis, which were regulated in DE model mice after HLJDD intervention. Generally, the results demonstrated that HLJDD had beneficial effects on DE, which could be mediated via ameliorating the metabolic disorders.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diabetic encephalopathy; Huang-Lian-Jie-Du Decoction; Metabolomics; UPLC-Q-Orbitrap HRMS/MS

Mesh:

Substances:

Year:  2020        PMID: 33039912     DOI: 10.1016/j.jpba.2020.113652

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  2 in total

1.  Danggui-Shaoyao-San Attenuates Cognitive Impairment via the Microbiota-Gut-Brain Axis With Regulation of Lipid Metabolism in Scopolamine-Induced Amnesia.

Authors:  Piaoxue Liu; Xun Zhou; Haoran Zhang; Rui Wang; Xiaolang Wu; Wenxuan Jian; Weirong Li; Dongsheng Yuan; Qi Wang; Wei Zhao
Journal:  Front Immunol       Date:  2022-05-19       Impact factor: 8.786

2.  The Distribution Pattern of Traditional Chinese Medicine Syndromes in 549 Patients with Type 2 Diabetes.

Authors:  Ge-Di Zhang; Xi-Xi Liu; Jia-Lang Liang; Qi-Ming Hu
Journal:  Diabetes Metab Syndr Obes       Date:  2021-05-17       Impact factor: 3.168

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.